Matthew Rimmer

Dr Matthew Rimmer is a Professor in Intellectual Property and Innovation Law at the Faculty of Law, at the Queensland University of Technology (QUT). He is a leader of the QUT Intellectual Property and Innovation Law research program, and a member of the QUT Digital Media Research Centre (QUT DMRC) the QUT Australian Centre for Health Law Research (QUT ACHLR), and the QUT International Law and Global Governance Research Program (QUT IP IL). Rimmer has published widely on copyright law and information technology, patent law and biotechnology, access to medicines, plain packaging of tobacco products, intellectual property and climate change, and Indigenous Intellectual Property. He is currently working on research on intellectual property, the creative industries, and 3D printing; intellectual property and public health; and intellectual property and trade, looking at the Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership, and the Trans-Atlantic Trade and Investment Partnership, and the Trade in Services Agreement. His work is archived at QUT ePrints SSRN Abstracts Bepress Selected Works.
  • Joined: October 7, 2013
  • Articles: 48

Misleading environmental marketing messages need regulation – A submission to the Australian Senate inquiry into greenwashing

[QUT] Australia needs a new, independent regulatory body and specific offences, penalties and remedies to curb deceptive ‘greenwashing’ marketing claims after the ACCC found the practice was rife among Australian companies... QUT law Professor Matthew Rimmer made the call in a submission to the Senate Standing Committee on Environment and Communications Inquiry into “greenwashing … and legislative options to protect consumers”. Professor Rimmer said Australia’s current regime for regulating greenwashing was fragmented and fractured. “It is split across consumer law, competition policy, corporations law, advertising standards, and intellectual property,” he said. “Australia needs a regulatory body, with specialist knowledge, to address misleading and deceptive environmental claims. There should be proper enforcement against the scourge of greenwashing in Australia.”

The TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19

This research event focused upon the geopolitical debate over access to essential medicines during the coronavirus public health crisis. I brought together researchers, experts and scholars working in the field of access to essential medicines — ranging through the disciplines of intellectual property, public health law, human rights, international law, and trade law.